S&P 500   4,595.04 (-1.29%)
DOW   34,656.96 (-1.36%)
QQQ   395.00 (-1.17%)
AAPL   164.28 (+2.52%)
MSFT   332.34 (-1.27%)
FB   327.82 (-3.02%)
GOOGL   2,856.00 (-1.88%)
AMZN   3,516.36 (-1.27%)
TSLA   1,137.66 (+0.06%)
NVDA   324.88 (-2.66%)
BABA   127.76 (-2.93%)
NIO   39.26 (-2.97%)
CGC   10.54 (-4.70%)
AMD   157.79 (-2.54%)
GE   95.64 (-2.80%)
MU   85.19 (-1.10%)
T   22.82 (-4.48%)
F   19.30 (-1.88%)
DIS   144.33 (-2.35%)
ACB   6.29 (-2.33%)
AMC   34.34 (-6.79%)
PFE   53.95 (+2.96%)
BA   196.42 (-1.05%)
S&P 500   4,595.04 (-1.29%)
DOW   34,656.96 (-1.36%)
QQQ   395.00 (-1.17%)
AAPL   164.28 (+2.52%)
MSFT   332.34 (-1.27%)
FB   327.82 (-3.02%)
GOOGL   2,856.00 (-1.88%)
AMZN   3,516.36 (-1.27%)
TSLA   1,137.66 (+0.06%)
NVDA   324.88 (-2.66%)
BABA   127.76 (-2.93%)
NIO   39.26 (-2.97%)
CGC   10.54 (-4.70%)
AMD   157.79 (-2.54%)
GE   95.64 (-2.80%)
MU   85.19 (-1.10%)
T   22.82 (-4.48%)
F   19.30 (-1.88%)
DIS   144.33 (-2.35%)
ACB   6.29 (-2.33%)
AMC   34.34 (-6.79%)
PFE   53.95 (+2.96%)
BA   196.42 (-1.05%)
S&P 500   4,595.04 (-1.29%)
DOW   34,656.96 (-1.36%)
QQQ   395.00 (-1.17%)
AAPL   164.28 (+2.52%)
MSFT   332.34 (-1.27%)
FB   327.82 (-3.02%)
GOOGL   2,856.00 (-1.88%)
AMZN   3,516.36 (-1.27%)
TSLA   1,137.66 (+0.06%)
NVDA   324.88 (-2.66%)
BABA   127.76 (-2.93%)
NIO   39.26 (-2.97%)
CGC   10.54 (-4.70%)
AMD   157.79 (-2.54%)
GE   95.64 (-2.80%)
MU   85.19 (-1.10%)
T   22.82 (-4.48%)
F   19.30 (-1.88%)
DIS   144.33 (-2.35%)
ACB   6.29 (-2.33%)
AMC   34.34 (-6.79%)
PFE   53.95 (+2.96%)
BA   196.42 (-1.05%)
S&P 500   4,595.04 (-1.29%)
DOW   34,656.96 (-1.36%)
QQQ   395.00 (-1.17%)
AAPL   164.28 (+2.52%)
MSFT   332.34 (-1.27%)
FB   327.82 (-3.02%)
GOOGL   2,856.00 (-1.88%)
AMZN   3,516.36 (-1.27%)
TSLA   1,137.66 (+0.06%)
NVDA   324.88 (-2.66%)
BABA   127.76 (-2.93%)
NIO   39.26 (-2.97%)
CGC   10.54 (-4.70%)
AMD   157.79 (-2.54%)
GE   95.64 (-2.80%)
MU   85.19 (-1.10%)
T   22.82 (-4.48%)
F   19.30 (-1.88%)
DIS   144.33 (-2.35%)
ACB   6.29 (-2.33%)
AMC   34.34 (-6.79%)
PFE   53.95 (+2.96%)
BA   196.42 (-1.05%)
NASDAQ:TRDA

Entrada Therapeutics News Headlines

$29.56
-0.74 (-2.44%)
(As of 11/30/2021 02:09 PM ET)
Add
Compare
Today's Range
$28.01
$31.63
50-Day Range
N/A
52-Week Range
$20.00
$36.85
Volume
6,983 shs
Average Volume
225,394 shs
Market Capitalization
$883.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Media Mentions By Week



Entrada Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TRDA
News Sentiment

0.50

0.27

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TRDA Articles
This Week

2

0

TRDA Articles
Average Week

Get Entrada Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRDA and its competitors with MarketBeat's FREE daily newsletter.

Entrada Therapeutics (NASDAQ:TRDA) News Headlines Today

SourceHeadline
MarketBeat logoEntrada Therapeutics (NASDAQ:TRDA) Coverage Initiated at Evercore ISI
americanbankingnews.com - November 24 at 8:14 AM
MarketBeat logoEntrada Therapeutics (NASDAQ:TRDA) Now Covered by The Goldman Sachs Group
americanbankingnews.com - November 23 at 8:38 AM
MarketBeat logoEntrada Therapeutics (NASDAQ:TRDA) Now Covered by Cowen
americanbankingnews.com - November 23 at 8:03 AM
Get Entrada Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRDA and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.